What’s Next in Preclinical Cancer Immunotherapy Research?
This webinar will include a panel discussion of key topics in the field of cancer immunotherapy, including new and emerging methods, recent publications, and future directions.
Targeting T Cells Within the Cancer Immunity Cycle
In this webinar, speakers will discuss the role of T cell biology in cancer immunotherapy.
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
Experts provide an overview of ex vivo and in vitro methods, techniques, and model systems for research within the cancer-immunity cycle framework.
Antibody Discovery by Single B Cell Screening on Beacon®
Amy Sheng, PhD provides an overview of antibody screening platforms and presents applications and case studies using the Beacon® platform for antibody screening.
The Cancer-Immunity Cycle: Research Solutions for Preclinical Immuno-Oncology
Cancer immunotherapy has undoubtedly expanded the cancer treatment landscape and improved patient outlook, which can in part be attributed to the recognition of the importance of the cancer-immunity cycle as a whole. In this blog, we provide an overview of the cancer-immunity cycle and highlight some preclinical models that can facilitate cancer immunotherapy research.
Video Game Therapy: A “Game Changer” for Post-COVID Brain Fog
Originally posted on Scientist.com, this article takes a look at post-COVID brain fog, its causes, and video game therapy as a potential treatment.
Long-Term Cardiovascular Symptoms of Mild COVID-19
Although the SARS-CoV-2 pandemic has been ongoing for more than two years, a clear understanding of the symptoms of long COVID remains elusive. In this blog post, we review a recent study published in Nature Medicine that investigated cardiovascular symptoms in individuals with prior mild SARS-CoV-2 infections.
Industry Insights with Amy Sheng on Nanobodies: An Important Tool for the Next Generation of Tumor Diagnostics and Therapeutics
Amy Sheng shares how nanobodies are emerging as important tools for tumor diagnosis and treatment.
Skin-on-Chip for Preclinical Herpes Disease Modeling
Organs-on-a-chip are attractive alternatives for bridging the translational gap between preclinical and clinical stages in vaccine development, particularly for herpes simplex virus (HSV). In this blog post, we review an article from Nature Communications on a skin-on-chip device for modeling HSV infection, as well as evaluating immune responses and antiviral drug efficacy (featured image © 2022 Sun et al., licensed under CC BY 4.0).
Talking Real Science with Gwen Randolph
This episode of Share Science features Gwen Randolph, PhD, a pathology and immunology professor at Washington University School of Medicine in St. Louis! Gwen shares some of her scientific passions, as well as personal experiences as a woman in science.
An Introduction to Infectious Disease Modeling
Hear ICON experts give an in-depth overview of infectious disease modeling with a focus on assessment of interventions and its challenges.
Extracellular Vesicles as Breast Cancer Biomarkers
Triple-negative breast cancer is particularly aggressive, challenging to treat, and accounts for 15-20% of all breast cancers. In this blog, we review a study published in Nature Communications that examines the transforming growth factor-β targetable signaling pathway, its role in malignant cancer progression and immune suppression, and tumor-derived extracellular vesicles as diagnostic and prognostic biomarkers.
Industry Insights with Yuning Chen on Recombinant Proteins
This episode of Share Science features Yuning Chen from Sino Biological, who provides insights into their extensive library of recombinant virus proteins, as well as the importance and value of these high quality reagents!
#ExpertAnswers: Valeria Fumagalli and Nancy Kouassi on the Syrian golden hamster model of COVID-19
Valeria Fumagalli and Nancy Kouassi discuss the Syrian golden hamster model of COVID-19, and present a new inhalation exposure-based mouse model using aerosolized SARS-CoV-2.
#ExpertAnswers: Bonnie Lun on Single-Domain Antibodies for Research
Dr. Bonnie Lun from Fortis Life Sciences discusses applications and advantages of using nanobodies for diagnostic and therapeutic research, and highlights Fortis/Abcore's single-domain antibody discovery services.
Single-Domain Antibodies: A Promising New Tool for Diagnostic and Therapeutic Research
Dr. Bonnie Lun answers questions about the applications and advantages of using nanobodies for diagnostic and therapeutic research.
Combination Therapy for Cancer Treatment
The combination of anti-cancer drugs, or combination therapy, has been hailed as a “cornerstone of cancer therapy” since it targets key pathways synergistically, thereby enhancing efficacy compared to monotherapies. This blog takes a look at a recent publication in Nature, which reported the effects of 2025 pairwise drug combinations in breast, colon, and pancreatic cell lines.
Unlocking Your Clinical Understanding of Post-Acute COVID Syndrome (PACS), Patient Recovery, and Risk of Subsequent Disease
Watch this webinar to learn about the metabolic changes during COVID-19 disease, how these can be accurately tracked and how NMR can improve the clinical understanding of Long-COVID.
Inhalable COVID-19 Vaccines: Recent Findings and Breakthroughs
Given that SARS-CoV-2 is primarily transmitted through respiratory droplets, with respiratory mucosa being the main viral entry route, is intramuscular administration the most effective vaccine delivery method to fight COVID-19? In this blog post, we have reviewed one recent study that reported the design and preclinical testing of an inhalable, exosome-based COVID-19 vaccine.
Does Diabetes Promote COVID-19, or Does COVID-19 Promote Diabetes?
During the COVID-19 pandemic, many of those living with diabetes were required to follow strict guidelines to protect themselves against infection as they were at high risk of morbidity and mortality. This blog takes a look at the links between angiotensin-converting enzyme 2 (ACE2) expression and diabetes, as well as incident diabetes and long COVID.
Novel Animal Models and Methods for Studying COVID-19: Golden Hamsters and Aerosolized SARS-CoV-2 Delivery
Experts present two novel animal models of COVID-19 and highlight recent research conducted using these models.
Talking Real Science with Gwen Randolph
This episode of #ShareScience features Gwen Randolph, PhD. She is passionate about the role of women in science, and she shares her personal experiences and passions as both a scientist and as a woman in the field of immunology.
Single-Domain Antibodies: A Promising New Tool for Diagnostic and Therapeutic Research
Dr. Bonnie Lun discusses applications and advantages of using single-domain antibodies for diagnostic and therapeutic research.
Recombinant Antibody Production: Current Methods and a Novel Antibody Generation Platform
Dr. Yuning Chen answers questions about recombinant antibody production and a novel antibody expression platform to facilitate antibody library generation.
#ExpertAnswers: Yuning Chen on Antibody Production
Yuning Chen discusses strategies involved in recombinant antibody production and introduces a novel antibody expression platform to facilitate antibody library generation.
